ARK BIOSCIENCES
Ark Biosciences is a biopharmaceutical company that is dedicated to the discovery and development of innovative therapeutics to address unmet medical need, especially in the area of respiratory viral infection and viral hepatitis, for global and China market. We strive to build a science-driven biopharmaceutical company that aims to be a leader in antiviral drug discovery and development. To achieve so, we aspire for the excellence of science and be innovative. We operate with a razor-sharp focus and aggressiveness with a timely and cost efficient manner. We create a healthy and rewarding work environment for employees, and seek a superior rate of return for investors and partners.
ARK BIOSCIENCES
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2014-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.arkbiosciences.com
Total Employee:
51+
Status:
Active
Contact:
+862161630331
Total Funding:
40.09 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF SSL By Default Mobile Non Scaleable Content JsDelivr Microsoft Exchange Online Office 365 Mail Pound Sterling
Similar Organizations
Ablynx
Ablynx is a biopharmaceutical company engaged in the discovery and development of nanobodies.
Akeso Biopharma
Akeso Biopharma is a biopharmaceutical company committed to the discovery, development, and commercialization of therapies.
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Genevide
Genevide is a biotech company that specializes in gene research and development.
Laekna Therapeutics
Laekna Therapeutics is a biotech company focusing on drug discovery and development.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Transcenta
Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.
Vidac Pharma
Vidac is a clinical stage innovative biopharmaceutical company dedicated to discovering
Current Advisors List
Board_member
Current Employees Featured
Jim Wu Founder and CEO @ Ark Biosciences
Founder and CEO
Haiqing Yuan Chief Science Officer @ Ark Biosciences
Chief Science Officer
2017-01-01
Founder
Investors List
Oriza Holdings
Oriza Holdings investment in Series D - Ark Biosciences
Oriental Fortune Capital
Oriental Fortune Capital investment in Series D - Ark Biosciences
Qiming Venture Partners
Qiming Venture Partners investment in Series D - Ark Biosciences
Longda Foods
Longda Foods investment in Series D - Ark Biosciences
Loyal Valley Capital
Loyal Valley Capital investment in Series D - Ark Biosciences
FTZ Fund
FTZ Fund investment in Series D - Ark Biosciences
Spinnotec
Spinnotec investment in Series C - Ark Biosciences
Hillhouse Investment
Hillhouse Investment investment in Series C - Ark Biosciences
Boquan Capital
Boquan Capital investment in Series C - Ark Biosciences
Yingke Capital
Yingke Capital investment in Series C - Ark Biosciences
Official Site Inspections
http://www.arkbiosciences.com Semrush global rank: 5.56 M Semrush visits lastest month: 1.3 K
- Host name: 47.100.242.78
- IP address: 47.100.242.78
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Ark Biosciences"
关于我们-爱科百发 - arkbiosciences.com
爱科百发拥有一支具有全球视野的跨学科研发及商业化管理团队， 汇聚了一批包括小分子化药、单抗、ADC 等不同分子形式的， 涵盖从药物发现、CMC、临床前及临床转化、注册申报等创新药从研发到商业化全流程的国内外领军人物及人才。See details»
About ArkBio - arkbiosciences.com
We are committed to our mission of driving R&D through innovation, addressing unmet medical needs of patients worldwide, building a healthy work environment for our employees, and …See details»
Ark Biosciences - 爱科百发
AK0529是全新的靶向呼吸道合胞病毒（RSV）融合蛋白小分子抑制剂，是全球同类首个（First-in-Disease）在III期临床试验中获得积极结果的RSV特效抗病毒药物，首个获国家药监局“突破性治疗品种”认定的非肿瘤创新药，即将递交新药上 …See details»
Ark Biosciences - Crunchbase Company Profile
Ark Biosciences is a biopharmaceutical company that is dedicated to the discovery and development of innovative therapeutics to address unmet …See details»
Ark Biosciences Company Profile | Management and Employees …
Find contact information for Ark Biosciences. Learn about their Research & Development, Business Services market share, competitors, and Ark Biosciences's email format.See details»
Ark Biosciences - Company Profile - Tracxn
Feb 21, 2025 Ark Biosciences - Chinese, clinical-stage biopharma developing small molecule therapeutics for respiratory viral infection and viral hepatitis. Raised funding over 3 rounds …See details»
Ark Biosciences Company Profile - Office Locations, Competitors
Ark Biosciences has 5 employees at their 1 location and $40 m in total funding,. See insights on Ark Biosciences including office locations, competitors, revenue, financials, executives, …See details»
Ark Biosciences - Overview, News & Similar companies - ZoomInfo
Nov 6, 2019 View Ark Biosciences (www.arkbiosciences.com) location in Shanghai, China , revenue, industry and description. Find related and similar companies as well as employees …See details»
Organization | Ark Biosciences Inc.
NOW Now Active Ingredients Indications Clinical Trials Targets and Mechanisms Alternative names Ark Biosciences | Ark Biosciences Inc. | Ark Biosciences Pty Ltd. | …See details»
ArkBio 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for ArkBio. Use the PitchBook Platform to explore the full profile.See details»
Ark Biosciences - Products, Competitors, Financials, Employees ...
Ark Biosciences is a biopharmaceutical company involved in the development of medicines for respiratory syncytial virus, attention deficit hyperactivity disorder, idiopathic pulmonary fibrosis, …See details»
Ark Biosciences Inc - Company Profile and News
Company profile page for Ark Biosciences Inc including stock price, company news, executives, board members, and contact informationSee details»
Ark Biosciences Profile - The Company Check
Dec 19, 2024 Ark Biosciences Private Limited, established in 2006, is engaged in the Food and Beverages sector in Mumbai. Explore their Corporate Structure, Financials, and More.See details»
Ark Biosciences-动脉网 - vbdata.cn
Ark Biosciences是一家生物制药公司，致力于发现和开发创新疗法，以满足全球和中国市场未满足的医疗需求，特别是在呼吸道病毒感染和病毒性肝炎领域。Ark Biosciences致力于建立一家科 …See details»
Ark Biosciences - Funding, Financials, Valuation & Investors
In funding over 6 rounds. Their latest funding was raised on Jul 14, 2022 from a Series D round. Ark Biosciences is funded by 34 investors. Oriza Holdings and Oriental Fortune Capital are the …See details»
Organization | Ark Biosciences Inc.
Ark Biosciences | Ark Biosciences Inc. | Ark Biosciences Pty Ltd. | info@arkbiosciences.com | Shanghai Ark Biopharmaceutical Co., Ltd.See details»
WuXi STA Forms Strategic Partnership with Ark Biopharmaceutical …
May 23, 2023 As a premier Contract Research, Development, and Manufacturing Organization (CRDMO), WuXi STA offers its worldwide partners efficient, flexible and high-quality solutions …See details»
Refocus On China: Ark Bio Evolves As It Plans Shanghai Listing
Shanghai-based Ark Biosciences has expanded its pipeline from the RSV-targeting drug ziresovir, licensed from Roche, to pediatric and fibrosis treatments, where there are largely untapped …See details»
About Us - ark-biotech.com
At Ark, we are transforming bioprocessing by championing a model-first approach that combines biology, chemistry, and physics with the predictive power of machine learning and AI.See details»
Ark Bio Company Profile: Funding, Investors & Partnerships
Oct 15, 2022 Ark is an end-to-end solution provider focused on cancer early detection. By harnessing advanced data science and proprietary miRNA detection technology, Ark develops …See details»